{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T12:30:57Z","timestamp":1782390657754,"version":"3.54.5"},"reference-count":70,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.neuropharm.2004.04.011","type":"journal-article","created":{"date-parts":[[2004,6,12]],"date-time":"2004-06-12T12:41:09Z","timestamp":1087044069000},"page":"390-400","source":"Crossref","is-referenced-by-count":96,"title":["The interaction of cannabinoids and opioids on pentylenetetrazole-induced seizure threshold in mice"],"prefix":"10.1016","volume":"47","author":[{"given":"Hamed","family":"Shafaroodi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morteza","family":"Samini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Moezi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houman","family":"Homayoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Sadeghipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Tavakoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Reza","family":"Hajrasouliha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad Reza","family":"Dehpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2004.04.011_BIB1","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0028-3908(84)90200-4","article-title":"The anticonvulsant effect of opioids and opioid peptides against maximal electroshock seizures in rats","volume":"23","author":"Berman","year":"1984","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00213-002-1144-9","article-title":"Involvement of the opioid system in the anxiolytic-like effects induced by delta(9)-tetrahydrocannabinol","volume":"163","author":"Berrendero","year":"2002","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB3","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1111\/j.1471-4159.1991.tb06379.x","article-title":"Cannabinoid receptor-regulated cyclic AMP accumulation in the rat striatum","volume":"57","author":"Bidaut-Russell","year":"1991","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB4","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/BF00426745","article-title":"A comparison of some pharmacological actions of morphine and delta9-tetrahydrocannabinol in the mouse","volume":"57","author":"Bloom","year":"1978","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB5","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1432-1033.1996.0704p.x","article-title":"Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression","volume":"237","author":"Bouaboula","year":"1996","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB6","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0014-2999(01)00766-X","article-title":"Intracerebral self-administration of the cannabinoid receptor agonist CP 55,940 in the rat: interaction with the opioid system","volume":"413","author":"Braida","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB7","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF00421539","article-title":"Anticonvulsant effects of cannabinoids in mice: drug interactions within cannabinoids and cannabinoid interactions with phenytoin","volume":"37","author":"Chesher","year":"1974","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB8","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/0024-3205(91)90154-4","article-title":"Opioid receptor-coupled second messenger systems","volume":"48","author":"Childers","year":"1991","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1749-6632.1992.tb25954.x","article-title":"Opioid and cannabinoid receptor inhibition of adenylyl cyclase in brain","volume":"654","author":"Childers","year":"1992","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB10","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1124\/jpet.102.045575","article-title":"Antinociceptive synergy between delta(9)-tetrahydrocannabinol and opioids after oral administration","volume":"304","author":"Cichewicz","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB11","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1124\/jpet.102.046870","article-title":"Modulation of oral morphine antinociceptive tolerance and naloxone-precipitated withdrawal signs by oral delta 9-tetrahydrocannabinol","volume":"305","author":"Cichewicz","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB12","first-page":"859","article-title":"Enhancement mu opioid antinociception by oral delta9-tetrahydrocannabinol: dose\u2013response analysis and receptor identification","volume":"289","author":"Cichewicz","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0014-2999(97)00144-1","article-title":"Delta 9-tetrahydrocannabinol increases proopiomelanocortin gene expression in the arcuate nucleus of the rat hypothalamus","volume":"323","author":"Corchero","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0165-0173(83)90039-5","article-title":"Pro- and anticonvulsant actions of morphine and the endogenous opioids: involvement and interactions of multiple opiate and non-opiate systems","volume":"287","author":"Frenk","year":"1983","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB16","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1600-0773.1988.tb01863.x","article-title":"Effect of mu- and kappa-opioid agonists on the electroconvulsive seizure threshold in mice and antagonism by naloxone and MR 2266","volume":"62","author":"Frey","year":"1988","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB17","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0024-3205(99)00290-8","article-title":"Cannabinoids as potential new analgesics","volume":"65","author":"Fuentes","year":"1999","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB18","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1523\/JNEUROSCI.22-03-01146.2002","article-title":"Motivational effects of cannabinoids are mediated by mu-opioid and kappa-opioid receptors","volume":"22","author":"Ghozland","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB19","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1211\/0022357011777891","article-title":"Protective effects of cannabinoid receptor agonists against cocaine and other convulsant-induced toxic behavioural symptoms","volume":"53","author":"Hayase","year":"2001","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB20","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1523\/JNEUROSCI.11-02-00563.1991","article-title":"Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study","volume":"11","author":"Herkenham","year":"1991","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB21","first-page":"1427","article-title":"Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1)","volume":"289","author":"Hillard","year":"1999","journal-title":"Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(02)02533-7","article-title":"Anticonvulsant effects of cyclosporin A on pentylenetetrazole-induced seizure and kindling: modulation by nitricoxidergic system","volume":"939","author":"Homayoun","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB23","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0920-1211(02)00018-9","article-title":"The involvement of endogenous opioids and nitricoxidergic pathway in the anticonvulsant effects of foot-shock stress in mice","volume":"49","author":"Homayoun","year":"2002","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0920-1211(01)00316-3","article-title":"The role of nitric oxide in anticonvulsant and proconvulsant effects of morphine in mice","volume":"48","author":"Homayoun","year":"2002","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB25","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1016\/0006-2952(89)90628-X","article-title":"Regulation of adenylate cyclase by cannabinoid drugs. Insights based on thermodynamic studies","volume":"38","author":"Howlett","year":"1989","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB26","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0028-3908(89)90166-4","article-title":"Pentylenetetrazol kindling in mice","volume":"28","author":"Karler","year":"1989","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB27","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0091-3057(02)01077-8","article-title":"Mediation of nitric oxide in inhibitory effect of morphine against electroshock-induced convulsions in mice","volume":"74","author":"Khavandgar","year":"2003","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.1528-1157.2001.0420s4007.x","article-title":"Animal models used in the screening of antiepileptic drugs","volume":"42","author":"Kupferberg","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB29","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0006-8993(78)90386-4","article-title":"Morphine induced alterations of gamma-aminobutyric acid and taurine contents and l-glutamate decarboxylase activity in rat spinal cord and thalamus: possible correlates with analgesic action of morphine","volume":"148","author":"Kuriyama","year":"1978","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB30","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1528-1157.2001.41499.x","article-title":"Anticonvulsant activity of N-palmitoylethanolamide, a putative endocannabinoid, in mice","volume":"42","author":"Lambert","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB31","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0028-3908(94)90002-7","article-title":"The activity of opioid analgesics in seizure models utilizing N-methyl-dl-aspartic acid, kainic acid, bicuculline and pentylenetetrazole","volume":"33","author":"Lauretti","year":"1994","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB32","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1126\/science.283.5400.401","article-title":"Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice","volume":"283","author":"Ledent","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB33","first-page":"1410","article-title":"l-deprenyl (selegiline) exerts anticonvulsant effects against different seizure types in mice","volume":"277","author":"Loscher","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB34","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0920-1211(91)90062-K","article-title":"The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III Pentylenetetrazole seizure models","volume":"8","author":"Loscher","year":"1991","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB35","first-page":"498","article-title":"Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells","volume":"44","author":"Mackie","year":"1993","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB36","doi-asserted-by":"crossref","first-page":"6552","DOI":"10.1523\/JNEUROSCI.15-10-06552.1995","article-title":"Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor","volume":"15","author":"Mackie","year":"1993","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB37","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0014-2999(96)00326-3","article-title":"Activation of the cannabinoid receptor by delta 9-tetrahydrocannabinol reduces gamma-aminobutyric acid uptake in the globus pallidus","volume":"308","author":"Maneuf","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB38","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/0166-2236(88)90093-8","article-title":"Anatomy of CNS opioid receptors","volume":"11","author":"Mansour","year":"1988","journal-title":"Trends, Neurosci."},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB39","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0165-6147(99)01339-5","article-title":"Pharmacological and biochemical interactions between opioids and cannabinoids","volume":"20","author":"Manzanares","year":"1999","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB40","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1126\/science.1088208","article-title":"CB1 cannabinoid receptors and on-demand defense against excitotoxicity","volume":"302","author":"Marsicano","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB41","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1038\/sj.bjp.0703990","article-title":"Reduction of opioid dependence by the CB(1) antagonist SR141716A in mice: evaluation of the interest in pharmacotherapy of opioid addiction","volume":"132","author":"Mas-Nieto","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB42","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0165-5728(01)00323-X","article-title":"Comparative characterization in the rat of the interaction between cannabinoids and opiates for their immunosuppressive and analgesic effects","volume":"117","author":"Massi","year":"2001","journal-title":"Neuroimmunology"},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB43","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0014-2999(87)90562-0","article-title":"Change in hypothermia and catalepsy induced by cannabinoids or morphine in mice tolerant to these substances","volume":"141","author":"Narimatsu","year":"1987","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB71","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/0006-8993(94)91283-1","article-title":"Antiepileptic effects of inhibitors of nitric oxide syntnase examined in pentylentetrazole-induced seizure in rats","volume":"663","author":"Osonoe","year":"1994","journal-title":"Brain Res"},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB44","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/0006-8993(86)91311-9","article-title":"Strain-dependent effects of shock-induced release of opioids: dissociation between analgesia and behavioral seizures","volume":"366","author":"Pavone","year":"1986","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB45","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0006-8993(95)00560-D","article-title":"Antisense oligodeoxynucleotides to the kappa-1 receptor block the antinociceptive effects of delta 9-THC in the spinal cord","volume":"689","author":"Pugh","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB46","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0304-3940(85)90362-3","article-title":"Pharmacological evidence for a protective role of the endogenous opioid system on electroshock-induced seizures in the mouse","volume":"62","author":"Puglisi-Allegra","year":"1985","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB47","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0014-2999(96)00752-2","article-title":"Potentiation of delta 9-tetrahydrocannabinol-induced analgesia by morphine in mice: involvement of mu- and kappa-opioid receptors","volume":"318","author":"Reche","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB48","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0028-3908(98)00005-7","article-title":"Inhibition of opioid-degrading enzymes potentiates delta9-tetrahydrocannabinol-induced antinociception in mice","volume":"37","author":"Reche","year":"1998","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB49","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0091-3057(97)00485-1","article-title":"Antisense oligodeoxynucleotides to the kappa1 receptor enhance delta9-THC-induced antinociceptive tolerance","volume":"59","author":"Rowen","year":"1998","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB50","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1016\/S0024-3205(00)00547-6","article-title":"Long-term treatment with SR141716A, the CB1 receptor antagonist, influences morphine withdrawal syndrome","volume":"66","author":"Rubino","year":"2000","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB51","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/0028-3908(82)90112-5","article-title":"Convulsant and anticonvulsant effects of opioids: relationship to GABA-mediated transmission","volume":"21","author":"Sagratella","year":"1982","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB52","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0006-8993(84)90426-8","article-title":"Activating endogenous opioid systems by electroconvulsive shock or footshock stress inhibits recurrent kindled seizures in rats","volume":"305","author":"Shavit","year":"1984","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB53","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1523\/JNEUROSCI.16-14-04322.1996","article-title":"Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures","volume":"16","author":"Shen","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB54","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1212\/WNL.57.11.2108","article-title":"Cannabinoids reduce levodopa-induced dyskinesia in Parkinson\u2019s disease: a pilot study","volume":"57","author":"Sieradzan","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB55","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1528-1157.1995.tb02576.x","article-title":"A review of the preclinical pharmacology of tiagabine: a potent and selective anticonvulsant GABA uptake inhibitor","volume":"36","author":"Suzdak","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB56","first-page":"2629","article-title":"Antiepileptic drugs: detection, quantification, and evaluation","volume":"44","author":"Swinyard","year":"1985","journal-title":"Fed. Proc."},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB57","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00213-003-1485-z","article-title":"Cannabinoids: reward, dependence, and underlying neurochemical mechanisms\u2014a review of recent preclinical data","volume":"169","author":"Tanda","year":"2003","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB58","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0014-2999(94)90003-5","article-title":"Evidence for a bidirectional cross-tolerance between morphine and delta 9-tetrahydrocannabinol in mice","volume":"260","author":"Thorat","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB59","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF00439112","article-title":"Influence of delta9-tetrahydrocannabinol and cannabidiol on photically evoked after-discharge potentials","volume":"52","author":"Turkanis","year":"1977","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB60","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1248\/cpb.46.1462","article-title":"Synthesis and pharmacological activities in mice of halogenated delta 9-tetrahydrocannabinol derivatives","volume":"46","author":"Usami","year":"1998","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB61","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1046\/j.0953-816x.2001.01558.x","article-title":"Delta9-tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effect","volume":"13","author":"Valverde","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB62","doi-asserted-by":"crossref","first-page":"9271","DOI":"10.1523\/JNEUROSCI.19-21-09271.1999","article-title":"The CB1 cannabinoid receptor can sequester G-proteins, making them unavailable to couple to other receptors","volume":"19","author":"Vasquez","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB63","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s00213-003-1451-9","article-title":"The cannabinoid receptor antagonist SR141716 attenuates overfeeding induced by systemic or intracranial morphine","volume":"168","author":"Verty","year":"2003","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB64","first-page":"697","article-title":"Analgesic, respiratory and heart rate effects of cannabinoid and opioid agonists in rhesus monkeys: antagonist effects of SR 141716A","volume":"286","author":"Vivian","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB65","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0014-2999(01)01243-2","article-title":"Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects","volume":"428","author":"Wallace","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB66","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0014-2999(02)02331-2","article-title":"Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity","volume":"452","author":"Wallace","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB67","first-page":"10","article-title":"Antinociceptive activity of intrathecally administered cannabinoids alone, and in combination with morphine, in mice","volume":"262","author":"Welch","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB68","first-page":"310","article-title":"Modulation of cannabinoid-induced antinociception after intracerebroventricular versus intrathecal administration to mice: possible mechanisms for interaction with morphine","volume":"272","author":"Welch","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB69","first-page":"1235","article-title":"Characterization of anandamide- and fluoroanandamide-induced antinociception and cross-tolerance to delta 9-THC after intrathecal administration to mice: blockade of delta 9-THC-induced antinociception","volume":"273","author":"Welch","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2004.04.011_BIB70","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0006-8993(00)02096-5","article-title":"Effects of differential modulation of mu-, delta- and kappa-opioid systems on bicuculline-induced convulsions in the mouse","volume":"862","author":"Yajima","year":"2000","journal-title":"Brain Res."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390804001170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390804001170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T22:58:35Z","timestamp":1549493915000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390804001170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":70,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S0028390804001170"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2004.04.011","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}